Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment

NCT02120547 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Insufficiency

Interventions

DRUG: Cenicriviroc in mild liver impaired
DRUG: Cenicriviroc in moderate liver impaired

Sponsor

Tobira Therapeutics, Inc.